Publication
COVID-19 vaccinations: summary guidance for Cancer patients in 28Languages: breaking barriers to Cancer patient Information
dc.contributor.author | Mauri, Davide | |
dc.contributor.author | Kamposioras, Konstantinos | |
dc.contributor.author | Tsali, Lampriani | |
dc.contributor.author | Dambrosio, Mario | |
dc.contributor.author | De Bari, Berardino | |
dc.contributor.author | Hindi, Nadia | |
dc.contributor.author | Salembier, Carl | |
dc.contributor.author | Nixon, Joanna | |
dc.contributor.author | Dimitrios, Tzachanis | |
dc.contributor.author | Alongi, Flippo | |
dc.contributor.author | Hameed, Hassan | |
dc.contributor.author | Valachis, Antonios | |
dc.contributor.author | Papadimitriou, Konstantinos | |
dc.contributor.author | Corradini, Stefanie | |
dc.contributor.author | Popovic, Lazar | |
dc.contributor.author | Kopecky, Jindrich | |
dc.contributor.author | Rodriguez, Andres | |
dc.contributor.author | Antunac, Katarina | |
dc.contributor.author | Yi, Junlin | |
dc.contributor.author | Lovey, Jozsef | |
dc.contributor.author | Strojan, Primoz | |
dc.contributor.author | Saraireh, Haytham | |
dc.contributor.author | Røtterud, Ranveig | |
dc.contributor.author | Chojnacka, Marzanna | |
dc.contributor.author | Olalla, Santa Cruz | |
dc.contributor.author | Chilingirova, Natalia | |
dc.contributor.author | De Mello, Ramon Andrade | |
dc.contributor.author | Amaral, Giovanna Araujo | |
dc.contributor.author | Arbabi, Farsid | |
dc.contributor.author | Vidra, Radu | |
dc.contributor.author | Rapushi, Erjeta | |
dc.contributor.author | Takeuchi, Dan | |
dc.contributor.author | Christopoulos, Chirstos | |
dc.contributor.author | Ivanova, Irina | |
dc.contributor.author | Djan, Igor | |
dc.contributor.author | Petricevic, Branka | |
dc.contributor.author | Cellini, Francesco | |
dc.contributor.author | Mihaylova, Iglika | |
dc.contributor.author | Plavetic, Natalija Dedic | |
dc.contributor.author | Kuhar, Cvetka Grašič | |
dc.contributor.author | Takeuchi, Elena | |
dc.contributor.author | Kountourakis, Pantelis | |
dc.contributor.author | Ntellas, Panagiotis | |
dc.contributor.author | Gazouli, Ioanna | |
dc.contributor.author | Gkoura, Stefania | |
dc.contributor.author | Yuce, Salih | |
dc.contributor.author | ER, Özlem | |
dc.contributor.author | Yasmina, Chait | |
dc.contributor.author | Kumaran, Gireesh | |
dc.contributor.author | Spahiu, Orges | |
dc.contributor.author | Yusuf, Aasim | |
dc.contributor.author | Gono, Paulina | |
dc.contributor.author | Apostolidis, Kathi | |
dc.contributor.author | Tolia, Maria | |
dc.date.accessioned | 2022-12-09T10:36:20Z | |
dc.date.available | 2022-12-09T10:36:20Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations' delivery and their application in the world's population and generates information inequalities across the different populations. Methods: Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries. Results: A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population. Conclusion: Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.2174/1574887116666211028145848 | pt_PT |
dc.identifier.issn | 1574-8871 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/18605 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Bentham Science Publishers | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Population | pt_PT |
dc.subject | Vaccination | pt_PT |
dc.subject | Cancer patients | pt_PT |
dc.subject | Languages | pt_PT |
dc.subject | Global | pt_PT |
dc.subject | Guidance | pt_PT |
dc.title | COVID-19 vaccinations: summary guidance for Cancer patients in 28Languages: breaking barriers to Cancer patient Information | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 14 | pt_PT |
oaire.citation.issue | 1 | pt_PT |
oaire.citation.startPage | 11 | pt_PT |
oaire.citation.title | Reviews on Recent Clinical Trials | pt_PT |
oaire.citation.volume | 17 | pt_PT |
person.familyName | de Mello | |
person.givenName | Ramon Andrade | |
person.identifier.orcid | 0000-0002-9640-4573 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 53ee625f-c5c3-468b-85bb-4cef5ad36928 | |
relation.isAuthorOfPublication.latestForDiscovery | 53ee625f-c5c3-468b-85bb-4cef5ad36928 |